Breakthrough Tracker record
Glud1 suppression supports roughly 500-fold functional mouse stem-cell expansion
Michihiro Hashimoto and collaborators report that inhibiting glutamate dehydrogenase 1 preserves self-renewing hematopoietic stem cells during division and produces approximately 500-fold expansion of functional mouse HSCs over 30 days under conventional culture conditions.
← Back to the filtered Breakthrough Tracker
- Stable ID
biology-glud1-mouse-hsc-expansion-2026- Revision
biology-glud1-mouse-hsc-expansion-2026.v1- Field
- Biology · Hematopoietic stem-cell biology and metabolism
- Evidence
- Tier 1 · Peer reviewed: Yes
- Record state
- Current · Peer-reviewed preclinical result
- Last checked
AI role
No substantive AI role was disclosed in the inspected journal record.
Record details
- Problem or result
- Metabolic control of ex vivo hematopoietic stem-cell self-renewal during division
- Authors
- Michihiro Hashimoto, Michie Uchikawa, Yuichiro Arima and collaborators
- Institutions
- Kumamoto University; University of Tokyo; Tokyo Women's Medical University; Chinese Academy of Medical Sciences; KAKETSUKEN
- Result date
- Published September 5, 2026
Why it matters
Sustaining functional HSC self-renewal during culture is a major regenerative-medicine bottleneck. The study identifies a metabolic lever linked to robust JAK2–STAT signaling rather than only another growth-factor cocktail.
Limits
The experiments are murine and ex vivo, not a demonstrated human therapy. Other HSC-expansion methods predate this work, so the novelty is the Glud1-linked mechanism and culture result, not first-ever expansion. Related patent applications and KAKETSUKEN-linked funding/employment are disclosed.
Sources
Correction and revision history
- 2026-09-07 — Added after primary-source, scope, status, AI-role and limitation review.
Machine-readable: JSON v1 · CSV v1 · Schema v1
This individual record remains noindex until a story-specific featured image passes Kingy’s rendered-pixel visual review. The source-linked tracker hub remains the public index.